- April 22, 2022
- Posted by: Stratford Team
- Category: Economy
The Biden administration may soon cripple America’s economy — inadvertently, of course.
Officials are reportedly giving serious consideration to a “march-in” petition, nominally filed by a handful of cancer patients but promoted by Knowledge Ecology International, the activist group founded by Ralph Nader. The petition urges the administration to relicense the patent on an advanced prostate cancer treatment — which is currently manufactured by Astellas Pharma — to generic drugmakers that could create cheaper knockoffs.
KEI, and a host of allied lawmakers like Sen. Elizabeth Warren, claim the Biden administration has the authority to do this thanks to a four-decade-old law, the Bayh-Dole Act. In the past, Republican and Democrat administrations have rejected similar petitions as both illegal and counterproductive.
But the Biden administration is getting desperate. The president’s approval ratings are underwater. Senior officials may feel…